Cargando…

A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination

Autoimmune diseases, including autoimmune endocrine diseases (AIED), are thought to develop following environmental exposure in patients with genetic predisposition. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and vaccines against it could represent new environmental triggers fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patrizio, Armando, Ferrari, Silvia Martina, Antonelli, Alessandro, Fallahi, Poupak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506108/ https://www.ncbi.nlm.nih.gov/pubmed/34653776 http://dx.doi.org/10.1016/j.jaut.2021.102738

Ejemplares similares

Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination
por: Patrizio, Armando, et al.
Publicado: (2022)

Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review
por: Patrizio, Armando, et al.
Publicado: (2022)

Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series
por: Fallahi, Poupak, et al.
Publicado: (2022)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

The Synergistic Effect of Corticosteroids and Mycophenolic Acid on Chemokines in Orbital Cells From Patients With Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2023)

Thyroid Autoimmunity and SARS-CoV-2 Infection
por: Fallahi, Poupak, et al.
Publicado: (2023)

MON-594 Report Of A Large Series Of Patients With Graves' Disease (with/without Graves' Ophthalmopathy) And Review Of The Literature, About The Association With Other Autoimmune Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Precision Medicine in Graves’ Disease and Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2021)

Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021)

Oral L‐thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study
por: Fallahi, Poupak, et al.
Publicado: (2018)

MON-LB102 Liquid L-Thyroxine Can Maintain Stable TSH Values in Patients with Hypothyroidism: A Prospective Study
por: Fallahi, Poupak, et al.
Publicado: (2019)

Oral Liquid L-Thyroxine (L-T4) May Be Better Absorbed in Comparison to L-T4 Tablets in Patients With Lactose Intolerance
por: Fallahi, Poupak, et al.
Publicado: (2021)

Graves Disease Following the SARS-CoV-2 Vaccine: Case Series
por: Weintraub, Michael A., et al.
Publicado: (2021)

Environmental Issues in Thyroid Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2017)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
por: Fallahi, Poupak, et al.
Publicado: (2019)

Chemokines in hyperthyroidism
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Graves’ disease following administration of second dose of SARS-CoV-2 vaccine
por: Goblirsch, Timothy James, et al.
Publicado: (2021)

Graves’ Thyrotoxicosis Following SARS-CoV-2 Infection
por: Harris, Asaf, et al.
Publicado: (2020)

Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies
por: Benvenga, Salvatore, et al.
Publicado: (2020)

ODP598 Liquid levothyroxine (L-T4) maintains more stable TSH levels in hypothyroid patients, than tablet L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

PSAT366 Liquid L-thyroxine (L-T4) Formulation Normalizes TSH in Hypothyroid Patients Treated with Tablets L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

FRI487 Oral Liquid L- Thyroxine (L-T4) Is More Effective In Controlling Hypothyroidism, Than L-T4 Tablet, In Patients Submitted To Total Thyroidectomy
por: Fallahi, Poupak, et al.
Publicado: (2023)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

SARS-CoV-2 vaccination related hyperthyroidism of Graves’ disease
por: Shih, Shyang-Rong, et al.
Publicado: (2022)

Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series
por: Fallahi, Poupak, et al.
Publicado: (2016)

MON-566 Early Diagnosis of Lymph Node Metastases by Serum Tg and Neck Ultrasonography, and Long Term Follow Up After Radioiodine and/or Surgical Treatment in Patients with Papillary or Follicular Thyroid Cancer.
por: Fallahi, Poupak, et al.
Publicado: (2019)

Autoimmune Endocrine Dysfunctions Associated with Cancer Immunotherapies
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Myoinositol in Autoimmune Thyroiditis
por: Paparo, Sabrina Rosaria, et al.
Publicado: (2022)

New-onset Graves’ disease following SARS-CoV-2 vaccination: a case report
por: Manta, Ringo, et al.
Publicado: (2022)

The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
por: Huang, LingHong, et al.
Publicado: (2022)

Cytokines and HCV-Related Disorders
por: Fallahi, Poupak, et al.
Publicado: (2012)

Personalization of Targeted Therapy in Advanced Thyroid Cancer
por: Fallahi, Poupak, et al.
Publicado: (2014)

Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection
por: Fallahi, Poupak, et al.
Publicado: (2014)

Increased Requirement of Replacement Doses of Levothyroxine Caused by Liver Cirrhosis
por: Benvenga, Salvatore, et al.
Publicado: (2018)

Systemic Lupus Erythematosus and Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2017)

Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia
por: Ferri, Clodoveo, et al.
Publicado: (2017)

Graves‘ disease following vaccination against SARS-CoV-2: A systematic review of the reported cases
por: Triantafyllidis, Konstantinos Katsikas, et al.
Publicado: (2022)

Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

L-T4 Therapy in Enteric Malabsorptive Disorders
por: Fallahi, Poupak, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lin1q1kuq6hkbhfadq4rgdgb4b